Onderneming Exact Sciences Corporation
Aandelen
EXAS
US30063P1057
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
58,79 USD | -7,04% | -7,39% | -20,53% |
15/04 | Exact Sciences Corporation kondigt wijzigingen in de leiding aan | CI |
11/04 | Exact Sciences tekent schuldruilovereenkomst, plaatsing van converteerbare obligaties | MT |
Vakgebied
Aantal werknemers: 6 550
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Screening
74,6
%
| 1 425 | 68,4 % | 1 865 | 74,6 % | +30,88% |
Precision Oncology
25,2
%
| 601 | 28,9 % | 629 | 25,2 % | +4,59% |
COVID-19 Testing
0,2
%
| 58 | 2,8 % | 6 | 0,2 % | -89,75% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
93,9
%
| 1 967 | 94,4 % | 2 346 | 93,9 % | +19,32% |
Non-United States
6,1
%
| 118 | 5,6 % | 153 | 6,1 % | +30,18% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Conroy
CEO | Chief Executive Officer | 58 | 18-03-09 |
Paul Limburg
CTO | Chief Tech/Sci/R&D Officer | - | 06-03-18 |
Jorge Garces
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-02-21 |
Chief Tech/Sci/R&D Officer | - | 01-01-19 | |
Tomasz Beer
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-22 |
D. Coward
BRD | Director/Board Member | 59 | 01-01-15 |
Kristen Weiler
SAM | Sales & Marketing | - | 01-01-18 |
Ana Hooker
PRN | Corporate Officer/Principal | 58 | 01-01-13 |
Kyle Stacey
AUD | Comptroller/Controller/Auditor | - | 01-01-09 |
James Herriott
LAW | General Counsel | 44 | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
D. Coward
BRD | Director/Board Member | 59 | 01-01-15 |
Kevin Conroy
CEO | Chief Executive Officer | 58 | 18-03-09 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 22-04-20 |
Timothy Scannell
BRD | Director/Board Member | 60 | 31-10-23 |
Daniel Levangie
BRD | Director/Board Member | 74 | 16-07-10 |
Katherine Napier
BRD | Director/Board Member | 69 | 24-04-09 |
Paul Clancy
BRD | Director/Board Member | 62 | 18-03-21 |
Pierre Jacquet
BRD | Director/Board Member | 57 | 25-07-19 |
James Doyle
BRD | Director/Board Member | 78 | 24-07-14 |
Director/Board Member | 74 | 03-03-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 181 530 967 | 179 701 553 ( 98,99 %) | 0 | 98,99 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Medical Specialties
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,53% | 10,67 mld. | |
+41,94% | 3,22 mld. | |
-36,56% | 2,09 mld. | |
-18,92% | 2,04 mld. | |
-29,19% | 1,46 mld. | |
+15,73% | 1 mld. | |
-4,37% | 734 mln. | |
-37,00% | 391 mln. | |
-46,73% | 379 mln. | |
+16,90% | 343 mln. |
- Beurs
- Aandelen
- Koers EXAS
- Onderneming Exact Sciences Corporation